Literature DB >> 213220

Defective in vitro lymphoproliferative responses to herpes simplex virus in patients with frequently recurring herpes infections during the disease-free interval.

H Kirchner, M Schwenteck, H Northoff, E Schöpf.   

Abstract

Entities:  

Mesh:

Year:  1978        PMID: 213220     DOI: 10.1016/0090-1229(78)90050-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  9 in total

Review 1.  Mechanisms of virus-induced immune suppression.

Authors:  M A Wainberg; E L Mills
Journal:  Can Med Assoc J       Date:  1985-06-01       Impact factor: 8.262

2.  Biosynthetic human interferon treatment of herpetic keratitis.

Authors:  G Smolin
Journal:  Trans Am Ophthalmol Soc       Date:  1983

3.  A possible psychoneuroimmunologic basis for recurrent genital herpes simplex.

Authors:  S M Bierman
Journal:  West J Med       Date:  1983-10

4.  Immunogenicity of purified glycoprotein gB of herpes simplex virus.

Authors:  Y Kino; T Eto; K Nishiyama; N Ohtomo; R Mori
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens.

Authors:  K O Kalimo; I A Joronen; V K Havu
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Correlation of herpes simplex virus antibody titers and specific lymphocyte stimulation in adult blood donors.

Authors:  H Moser; F Behrens; R Ziegelmaier; J Hilfenhaus; R Mauler
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

7.  Animal studies on the efficacy of vaccination against recurrent herpes.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

8.  Alteration of lymphocyte transformation response to herpes simplex virus infection by acyclovir therapy.

Authors:  W E Lafferty; L A Brewer; L Corey
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

9.  In vitro studies on the human cellular immune response to commercially available herpes simplex antigens.

Authors:  B M Czarnetzki; E Macher
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.